Prognostic impact of histological subtypes in non-muscle-invasive UTUC: Propensity matched analysis. Overall survival and biomarker results of NURE-Combo: A phase 2 study of neoadjuvant nivolumab ...
Bladder cancer arises from the lining of the bladder, the organ that stores urine, and is one of the most common cancers in ...
In a phase 1 study, an erdafitinib intravesical drug-releasing system showed preliminary safety as well as efficacy in NMIBC with FGFR alterations. TAR-210, an erdafitinib intravesical drug-releasing ...
Aberrations in fibroblast growth factor receptors FGFR2/3 are major drivers of many cancers-including intrahepatic cholangiocarcinoma, endometrial, breast, gastric, and bladder cancers. However, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results